Skip to content

Preventing Diabetes in Latino Families

Preventing Diabetes in Latino Families

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05228522
Enrollment
132
Registered
2022-02-08
Start date
2021-12-12
Completion date
2026-07-31
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Pediatric Obesity, Type 2 Diabetes

Brief summary

Purpose: This study will test the efficacy of a family-focused lifestyle intervention for reducing type 2 diabetes (T2D) risk factors and increasing Quality of Life (QoL) among high-risk Latino families.

Detailed description

Background: T2D disproportionately impacts Latino children, families and communities. The Diabetes Prevention Program (DPP) established that T2D can be prevented in high-risk adults through intensive lifestyle intervention. Although the DPP has been translated to a variety of adult populations and settings, engagement and effectiveness is diminished in minority communities and there are no family-focused diabetes prevention trials for Latinos. The culturally-grounded approach is guided by an Ecodevelopmental model that considers community, family, peer, and individual-level factors that influence health behaviors and health outcomes over time. The study will test the efficacy of a 16-week family-focused lifestyle intervention for reducing T2D risk and increasing QoL among high-risk Latino families as compared to control families. The study will use Integrative Mixed Methods to understand how family structures and processes influence intervention outcomes.

Interventions

BEHAVIORALLifestyle Intervention

16-week family-focused intervention that includes nutrition education, behavioral change skills training, and physical activity.

Sponsors

Arizona State University
Lead SponsorOTHER
St. Vincent de Paul Medical and Dental Clinic
CollaboratorOTHER
Valley of the Sun YMCA, Arizona
CollaboratorOTHER
University of Washington
CollaboratorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 99 Years
Healthy volunteers
Yes

Inclusion criteria

Inclusion/

Exclusion criteria

- Children Inclusion * Latino: self-report * Age: 10-16 years * Obesity: BMI ≥ 95th percentile for age and sex Exclusion * Type 2 diabetes: (standard American Diabetes Association criteria) * Taking medication(s) or diagnosed with a condition that influences carbohydrate metabolism, physical activity, and/or cognition * Currently enrolled in (or within previous 12 months) a formal diabetes prevention or weight loss program * Self-identify as American Indian * Unstable depression or other mental health condition that may impact QoL II. Inclusion/

Design outcomes

Primary

MeasureTime frameDescription
Glucose Tolerance16 weeksGlucose tolerance will be determined using a standard 75-gram Oral Glucose Tolerance Test (OGTT) with samples collected at fasting and 120 minutes for assessment of glucose concentrations. We will follow the OGTT protocol used by the CDC for the NHANES. Centers for Disease Control. Oral Glucose Tolerance Test (OGTT) Procedures Manual. In: Survey NHaNE, ed2007.

Secondary

MeasureTime frameDescription
Weight Specific Quality of Life (QoL)16 weeksYouth Quality of Life (YQOL) inventory shows strong psychometric properties, internal consistency (Chronbach's alpha \>0.80), test-retest reliability (ICC \> 0.74), and construct validity with other pediatric QoL measures (r = 0.73, P\<0.05 with KINDL). Weight-specific QoL (YQOL-W) measures three domains of weight-related QoL (Self, Social, Environmental). The instrument shows good reliability (ICC = 0.77) and construct validity with the Children's Depression Inventory (r=0.57, P\<0.01). Adults will be assessed using the World Health Organization Brief Quality of Life Instrument, demonstrates good to excellent psychometric properties. Weight-specific QoL in adults will be assessed by the Obesity and Weight-Loss Quality of Life (OWLQOL) instrument which demonstrates strong psychometric properties internal consistency (Chronbach's alpha \>0.90), test-retest reliability (ICC \> 0.95), and construct validity with other QoL measures (r = 0.53, P\<0.05).
Total body composition-muscle16 weeksMuscle (grams) will be assessed by Dual-energy X-Ray Absorptiometry (DXA) using the GE Lunar iDXA (GE Lunar, Madison, WI).
Total body composition-fat16 weeksFat (grams) will be assessed by Dual-energy X-Ray Absorptiometry (DXA) using the GE Lunar iDXA (GE Lunar, Madison, WI).
Total body composition-bone16 weeksBone density (grams) will be assessed by Dual-energy X-Ray Absorptiometry (DXA) using the GE Lunar iDXA (GE Lunar, Madison, WI).
Physical Activity16 weeksPhysical Activity will be assessed using accelerometers (Actigraph wGT3X-BT) to capture minutes/day of moderate, moderate to vigorous, and vigorous activity over 7-days with \>4 days and \>10 hours/day determined as valid. Data will be processed and analyzed using ActiLife v6.13 software.
Dietary behaviors16 weeksDietary behaviors will be assessed using the NCI ((National Cancer Institute) Dietary Screener Questionnaire. To score the questionnaire, we use the NCI's (National Cancer Institute) scoring algorithms to convert screener responses to estimates of individual dietary intake for fruits and vegetables (cup equivalents), dairy (cup equivalents), added sugars (teaspoon equivalents), whole grains (ounce equivalents), fiber (g), and calcium (mg) with higher values indicating greater intake. For a fuller description of the statistical methods used, see: Thompson FE, Midthune D, Kahle L, Dodd KW. Development and Evaluation of the National Cancer Institute's Dietary Screener Questionnaire Scoring Algorithms. J Nutrition 2017 Jun;147(6):1226-1233.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 28, 2026